CGEOX
Price
$17.76
Change
+$0.17 (+0.97%)
Updated
Jan 17 closing price
Net Assets
145.21M
RPEBX
Price
$61.60
Change
+$0.39 (+0.64%)
Updated
Jan 17 closing price
Net Assets
144.81B
Ad is loading...

CGEOX vs RPEBX

Header iconCGEOX vs RPEBX Comparison
Open Charts CGEOX vs RPEBXBanner chart's image
Calamos Global Equity R6
Price$17.76
Change+$0.17 (+0.97%)
VolumeN/A
Net Assets145.21M
American Funds New Perspective R2E
Price$61.60
Change+$0.39 (+0.64%)
VolumeN/A
Net Assets144.81B
CGEOX vs RPEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CGEOX vs. RPEBX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEOX is a StrongBuy and RPEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 145B vs. CGEOX (145M). RPEBX pays higher dividends than CGEOX: RPEBX (0.46) vs CGEOX (0.11). CGEOX was incepted earlier than RPEBX: CGEOX (5 years) vs RPEBX (10 years). CGEOX is a more actively managed with annual turnover of: 90.00 vs. RPEBX (17.00). CGEOX has a lower initial minimum investment than RPEBX: CGEOX (0) vs RPEBX (250). CGEOX annual gain was more profitable for investors over the last year : 19.76 vs. RPEBX (14.72).
CGEOXRPEBXCGEOX / RPEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years10 years-
Gain YTD1.1972.03759%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets145M145B0%
Annual Yield % from dividends0.110.4624%
Returns for 1 year19.7614.72134%
Returns for 3 years12.271.171,050%
Returns for 5 yearsN/A29.02-
Returns for 10 yearsN/A71.73-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADSE15.610.55
+3.65%
Ads-Tec Energy PLC
ARHS11.640.23
+2.02%
Arhaus
EDIT1.22-0.02
-1.61%
Editas Medicine
GTLB63.02-1.18
-1.84%
GitLab
DWTX1.87-0.06
-3.11%
Dogwood Therapeutics Inc